Basal insulin dose in 40 type 1 diabetic patients remains stable 1year after educational training in flexible insulin therapy;La dose d'insuline basale déterminée chez 40 diabétiques de type 1 par une éducation thérapeutique à l'insulinothérapie fonctionnelle demeure stable à un an

Diabetes and Metabolism

Volumn 36, Issue 5, 2010, Pages 369-374

  Benhamou, P Y ^a   Garnier, C ^a   Debaty, I ^a   Rueff, A ^a   Gilbert, C ^a   Ressel, M ^a   Siaud, C ^a   Boudrot, E ^a   Carpentier, B ^a   Boizel, R ^a   Nasse, L ^a   Halimi, S ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Basal insulin; Flexible insulin therapy; Therapeutic education; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN GLARGINE; ISOPHANE INSULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BASAL INSULIN DOSE; BLOOD GLUCOSE MONITORING; BODY WEIGHT; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; DISEASE DURATION; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; POSTPRANDIAL STATE; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; FEMALE; FOOD; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INSULIN; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; RETROSPECTIVE STUDIES; SELF ADMINISTRATION; WEIGHT GAIN;

EID: 78649444847     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2010.03.006     Document Type: Article

References (14)

1. Hanaire-Broutin H. Insulinothérapie et autosurveillance glycémique: schéma thérapeutique et recommandations. Diabetes Metab 2003, 29. 2S21-2S25.
2. Muhlhauser I., Bruckner I., Berger M., Cheta D., Jörgens V., Ionescu-Tîrgoviste C., et al. Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Dusseldorf Study. Diabetologia 1987, 30:681-690.
3. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002, 325:746-749. DAFNE Study Group.
4. 1c and frequency of severe hypoglycemia. An observational cohort study. Diabetes Metab 2003, 29:53-57.
5. Franc S., Dardari D., Boucherie B., Riveline J.P., Biedzinski M., Petit C., et al. Real-life application and validation of flexible intensive insulin therapy algorithms in type 1 diabetes patients. Diabetes Metab 2009, 35:463-468.
6. Sachon C., Heurtier A., Grimaldi A. So-called "functional" insulin therapy. Diabetes Metab 1998, 24:556-559.
7. Grimm J.J., Hegar K., Berger W. Functional insulin therapy in the type 1 diabetic. Journ Annu Diabetol Hotel Dieu 2000, 145-154.
8. Rabasa-Lhoret R., Garon J., Langelier H., Poisson D., Chiasson J.L. Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen. Diabetes Care 1999, 22:667-673.
9. Plank J., Kohler G., Rakovac I., et al. Long-term evaluation of a structured outpatient education programme for intensified insulin therapy in patients with Type 1 diabetes: a 12-year follow-up. Diabetologia 2004, 47:1370-1375.
10. Grimm J.J., Berger W., Ruiz J. Functional insulin therapy: patient education and algorithms. Diabetes Metab 2002, 28(4 Pt 2). 2S15-2S8.
11. Howorka K., Thoma H., Grillmayr H., Kitzler E. Phases of functional, near-normoglycaemic insulin substitution: what are computers good for in the rehabilitation process in type I (insulin-dependent) diabetes mellitus?. Comput Methods Programs Biomed 1990, 32:319-323.
12. Hanaire-Broutin H., Melki V., Bessieres-Lacombe S., Tauber J.P. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes. Diabetes Care 2000, 23:1232-1235.
13. Hirsch I.B., Bode B.W., Garg S., et al. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care 2005, 28:533-538.
14. Lepore G., Dodesini A.R., Nosari I., Trevisan R. Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: an open parallel long-term study. Diabetes Nutr Metab 2004, 17:84-89.